Cochrane · systematic review · CD008190
Appetite stimulants for people with cystic fibrosis
McTavish, D, Thornton, J · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlyAppetite stimulants versus placebo for people with cystic fibrosis
Population: people with cystic fibrosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Change in weight (kg) Appetite stimulants vs placebo | no estimate extracted | 2 studies · 42 participants | Low Downgraded: risk of bias, imprecision |
Change in weight (kg) Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Low Downgraded: risk of bias, imprecision |
Change in weight z score Appetite stimulants vs placebo | no estimate extracted | 3 studies · 40 participants | Low Downgraded: risk of bias, imprecision |
Change in weight z score Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Low Downgraded: risk of bias, imprecision |
Change in FEV1 % predicted Appetite stimulants vs placebo | no estimate extracted | 2 studies · 42 participants | Low Downgraded: risk of bias, imprecision |
Change in FEV1 % predicted Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Low Downgraded: risk of bias, imprecision |
Increase in appetite (subjective reporting) Appetite stimulants vs placebo | OR 45.25 [3.57, 573.33] | 2 studies · 23 participants | Low Downgraded: risk of bias, imprecision |
Appetite stimulants versus placebo for people with cystic fibrosis
Population: people with cystic fibrosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Change in weight (kg) ‐ at 3 months Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Moderate Downgraded: risk of bias |
Change in weight (kg) ‐ at 6 months Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Moderate Downgraded: risk of bias |
Change in weight z score ‐ at 3 months Appetite stimulants vs placebo | no estimate extracted | 3 studies · 40 participants | Moderate Downgraded: risk of bias |
Change in weight z score ‐ at 6 months Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Moderate Downgraded: risk of bias |
Change in FEV1 (% predicted) ‐ at 3 months Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Moderate Downgraded: risk of bias |
Change in FEV1 (% predicted) ‐ at 6 months Appetite stimulants vs placebo | no estimate extracted | 1 study · 17 participants | Moderate Downgraded: risk of bias |
Increase in appetite (subjective reporting) Appetite stimulants vs placebo | OR 45.25 [3.57, 573.33] | 2 studies · 23 participants | Moderate Downgraded: risk of bias |